Without adapting JCA to include assessment of real world data (RWD) and broader benefits, vaccines may be undervalued, ...

Merck (known as MSD outside the US and Canada) has entered into a definitive agreement to acquire Cidara Therapeutics, a ...

Novartis has reported positive top-line results from the phase 3 KALUMA trial evaluating KLU156 (ganaplacide/lumefantrine, or ...

Biogen and Eisai have announced that the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has approved an ...

Johnson & Johnson (J&J) has received a positive recommendation from the UK’s National Institute for Health and Care ...

InflaRx – a biopharmaceutical company developing anti-inflammatory therapeutics targeting the complement system – has ...

PMEA returned on 19 November to the Sheraton Grand in London to recognise excellence within pharmaceutical marketing. The ...

AstraZeneca has reported positive full results from its phase 3 NATRON trial evaluating Fasenra (benralizumab) for the ...

VML Portugal has announced the launch of VML Health, with pharma communications veteran Mariana Marta dos Santos being ...

For decades, menopause has been swept under the rug, or into the dark corners of clinicians’ offices, often dismissed as ...

Amgen has reported positive results from its phase 3 VESALIUS-CV trial, which demonstrated that Repatha (evolocumab) ...

The true measure of a medical leader is the courage to act when existing systems fail the patient. This is the professional ...